Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Sohini Mondal

Insulet Stock: Is PODD Outperforming the Healthcare Sector?

With a market cap of $18.4 billion, Insulet Corporation (PODD) is a leading developer of innovative insulin delivery systems for people with insulin-dependent diabetes. The company's flagship product, the Omnipod System, offers a tubeless, wearable insulin pump with wireless capabilities, providing a discreet and easy-to-use solution for continuous insulin delivery. 

Companies valued at more than $10 billion are generally classified as “large-cap” stocks, and Insulet fits this criterion perfectly. Headquartered in Acton, Massachusetts, Insulet also partners with pharmaceutical and biotechnology companies to expand the application of its technology for the delivery of other subcutaneous drugs.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.